Panacea Biotec Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve Standalone and Consolidated ....
PANACEABIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Panacea Biotec has notified exchanges that its Board meeting is scheduled for May 29, 2026 to consider and approve the audited financial results for Q4 and the full financial year ended March 31, 2026. The meeting will also take up the matter of dividend recommendation on equity and preference shares for FY 2025-26. The company has confirmed that the trading window remains closed for all designated persons from April 1, 2026 till May 31, 2026, and will reopen from June 1, 2026. This is a routine regulatory intimation under SEBI LODR Regulations and does not contain actual financial numbers.
This is a standard pre-results announcement notice. The actual impact on shareholders will depend on the financial results to be approved on May 29, 2026. Until then, the stock may remain in a trading blackout period.